Biotechnology
FDA provides a positive pre-IND response to Alzamend Neuro for AL001.
Alzamend Neuro, Inc. (Nasdaq:ALZN) is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder, major depressive disorder (“MDD”), and post-traumatic stress disorder (“PTSD”), announced today ... [Read]
Consumer
Xponential Fitness broadens its international reach with the Club Pilates deal in the UK
Xponential Fitness (NYSE: XPOF) reported signing its first Master Franchise Agreement in the UK, With an agreement for Club Pilates across England, Scotland, Wales, and Northern Ireland. The contract allows the master franchisee to grant ... [Read]
Oil & Gas
Providence Resources Plc Names Alan Curran as its Acting CEO
Energy business Providence Resources Plc (PVR), based in Ireland, announced that Alan Curran had been named Interim Chief Executive as of July 4. James Menton returns to his position as non-executive Chairman of the Board ... [Read]
Tech
Cronos Group and Geocann Work Together to Use VESIsorb® Delivery Technology for Quicker Absorption
In collaboration with Geocann, Cronos Group Inc. is happy to announce the release of the first of what is anticipated to be several products that will make use of the cutting-edge VESIsorb® delivery system. Faster ... [Read]
Cannabis
Agrify Enters the Lucrative New Zealand Cannabis Market With End-To-End Solutions for Cultivation and Extraction Through Sales and SAAS Licensing Agreement With Ora Pharm.
AgrifyTM Corporation, the most cutting-edge supplier of advanced cultivation and extraction solutions for the cannabis industry, announced it has signed a legally binding agreement (the “Agreement”) to provide Ora Pharm, a Waikato, New Zealand-based health ... [Read]
Biotechnology
Amryt to Pursue Formal Dispute Resolution for Oleogel-S10 (Filsuvez®) NDA
Amryt (Nasdaq: AMYT), a multinational, commercial-stage biopharmaceutical company with a focus on acquiring, developing, and commercializing novel treatments for rare diseases, today announced its intention to submit a Formal Dispute Resolution Request (FDRR) for its ... [Read]
Biotechnology
Eton Pharmaceuticals Sells Hospital Supplies to Dr. Reddy’s for up to $50M
Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today declared that it had agreed to sell its hospital goods to Dr. Reddy’s Laboratories SA, a ... [Read]
Beverages
Splash Beverage Group Enters into Agreement to Purchase 80% of Pulpoloco Sangria
Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of well-known beverage brands, announced today that it has signed a contract to purchase 80 percent of Pulpoloco Sangria. As a ... [Read]
Biotechnology
Evaxion Biotech Broadens EVX-03 DNA Vaccine Project Into Non-Small Cell Lung Cancer.
Evaxion Biotech A/S (NASDAQ: EVAX) a clinical-stage biotechnology company focused on the creation of AI-driven immunotherapies, announced today that it has chosen EVX-03 as the product candidate within its DNA technology platform to target a ... [Read]
Biotechnology
Optimi Health Requests for Authorization to Manufacture MDMA, Other Synthetic Psychedelics
Optimi Health Corp, a native Canadian business that creates natural, scalable, and affordable mushroom formulations for transformational human experiences, has made a health request to Canada for an amendment to the Controlled Substances Dealer’s Licence. ... [Read]